Safety and immunogenicity of boosting with a severe acute respiratory syndrome coronavirus 2 omicron variant mRNA vaccine in healthy adults: An open-label, and single-arm Phase 1 study

被引：1

作者：

Hannawi, Suad ^{[1
]}

Zhang, Rong-Rong ^{[2
]}

Abuquta, Alaa ^{[3
]}

Safeldin, Linda ^{[4
]}

Hassan, Aala ^{[4
]}

Alamadi, Ahmad ^{[4
]}

Hossain, Tasmiah ^{[4
]}

Mostafa, Mohamed ^{[5
]}

Ghoneim, Yasser ^{[5
]}

Solo, Jennifer ^{[5
]}

Zheng, Hong-Xia ^{[6
]}

Wu, Ding-Feng ^{[6
]}

Yu, Dan-Dan ^{[6
]}

Yuan, Jia-Cheng ^{[6
]}

Zhao, Di ^{[6
]}

Lin, Rui ^{[6
]}

Ying, Bo ^{[6
,8
]}

Qin, Cheng-Feng ^{[2
,7
]}

机构：

[1] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Internal Med Dept, Emirates Hlth Serv EHS, Dubai, U Arab Emirates

[2] Acad Mil Med Sci AMMS, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China

[3] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Accid & Emergency Dept, EHS, Dubai, U Arab Emirates

[4] Minist Hlth & Prevent, Al Kuwait Dubai Hosp, Gen Surg Dept, EHS, Dubai, U Arab Emirates

[5] PDC FZ LLC, Contract Res Org, Dubai, U Arab Emirates

[6] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou, Peoples R China

[7] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China

[8] Suzhou Abogen Biosci Co Ltd, Abogen Biosci, Suzhou 215123, Peoples R China

来源：

CLINICAL AND TRANSLATIONAL MEDICINE | 2023年 / 13卷 / 08期

关键词：

D O I：

10.1002/ctm2.1387

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页数：4

共 50 条

[31] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
Ito, Shuichi
Nishiyama, Yuya
Sugiura, Kenkichi
Enya, Kazuaki
CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2022, 26 (04) : 350 - 358
[32] Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study
Shuichi Ito
Yuya Nishiyama
Kenkichi Sugiura
Kazuaki Enya
Clinical and Experimental Nephrology, 2022, 26 : 350 - 358
[33] Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials
Gaudinski, Martin R.
Houser, Katherine V.
Morabito, Kaitlyn M.
Hu, Zonghui
Yamshchikov, Galina
Rothwell, Ro Shauna
Berkowitz, Nina
Mendoza, Floreliz
Saunders, Jamie G.
Novik, Laura
Hendel, Cynthia S.
Holman, LaSonji A.
Gordon, Ingelise J.
Cox, Josephine H.
Edupuganti, Srilatha
McArthur, Monica A.
Rouphael, Nadine G.
Lyke, Kirsten E.
Cummings, Ginny E.
Sitar, Sandra
Bailer, Robert T.
Foreman, Bryant M.
Burgomaster, Katherine
Pelc, Rebecca S.
Gordon, David N.
DeMaso, Christina R.
Dowd, Kimberly A.
Laurencot, Carolyn
Schwartz, Richard M.
Mascola, John R.
Graham, Barney S.
Pierson, Theodore C.
Ledgerwood, Julie E.
Chen, Grace L.
LANCET, 2018, 391 (10120): : 552 - 562
[34] Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
Yap, Timothy A.
Nakagawa, Kazuhiko
Fujimoto, Nobukazu
Kuribayashi, Kozo
Guren, Tormod Kyrre
Calabro, Luana
Shapira-Frommer, Ronnie
Gao, Bo
Kao, Steven
Matos, Ignacio
Planchard, David
Chatterjee, Arkendu
Jin, Fan
Norwood, Kevin
Kindler, Hedy L.
LANCET RESPIRATORY MEDICINE, 2021, 9 (06): : 613 - 621
[35] Apremilast for Discoid Lupus Erythematosus: Results of a Phase 2, Open-Label, Single-Arm, Pilot Study
De Souza, Aieska
Strober, Bruce E.
Merola, Joseph F.
Oliver, Stephen
Franks, Andrew G., Jr.
JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1224 - 1226
[36] The Number of Coronavirus Disease 2019 Vaccine Doses and Severe Clinical Outcomes in Older Patients Infected With a Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant
Furukawa, Koichi
Kurahashi, Yukiya
Ishimaru, Hanako
Nishimura, Mitsuhiro
Arii, Jun
Sano, Shigeru
Tohma, Yoshiki
Ohkita, Hiroyuki
Nakamura, Sachiko
Iwata, Sachiyo
Mori, Yasuko
JOURNAL OF INFECTIOUS DISEASES, 2022, 226 (11): : 2041 - 2042
[37] Immunogenicity and safety of Southern Hemisphere inactivated quadrivalent influenza vaccine: a Phase III, open-label study of adults in Brazil
Zerbini, Cristiano A. F.
dos Santos, Rodrigo Ribeiro
Nunes, Maria Jose
Soni, Jyoti
Li, Ping
Jain, Varsha K.
Ofori-Anyinam, Opokua
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2017, 21 (01): : 63 - 70
[38] A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults
Andras Nagy
Kimberly Duff
Alexander Bauer
Fred Okonneh
Juan Carlos Rondon
Leman Yel
Zhaoyang Li
Journal of Clinical Immunology, 2024, 44
[39] A Phase 1 Open-Label Study to Assess the Tolerability, Safety, and Immunogenicity of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 20% in Healthy Adults
Nagy, Andras
Duff, Kimberly
Bauer, Alexander
Okonneh, Fred
Rondon, Juan Carlos
Yel, Leman
Li, Zhaoyang
JOURNAL OF CLINICAL IMMUNOLOGY, 2024, 44 (01)
[40] Safety and Efficacy of Apatinib Monotherapy for Unresectable, Metastatic Esophageal Cancer: A Single-Arm, Open-Label, Phase II Study
Li Yanwei
Feng, He
Ren, Peng
Yue, Jie
Zhang, Wencheng
Tang, Peng
Shang, Xiaobin
Pang, Qingsong
Liu, Dongying
Chen, Chuangui
Pan, Zhanyu
Tao, Yu Zhen
ONCOLOGIST, 2020, 25 (10): : E1464 - E1472

← 1 2 3 4 5 →